| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 9.909 | 14.808 | 16.631 | 16.321 | 11.857 | 16.938 | 15.324 | 23.176 | 24.115 |
| Total Income - EUR | - | 9.909 | 14.816 | 16.631 | 16.321 | 11.857 | 16.938 | 15.324 | 23.176 | 24.115 |
| Total Expenses - EUR | - | 242 | 675 | 73 | 82 | 306 | 285 | 1.154 | 8.159 | 10.408 |
| Gross Profit/Loss - EUR | - | 9.667 | 14.141 | 16.558 | 16.240 | 11.551 | 16.653 | 14.170 | 15.016 | 13.707 |
| Net Profit/Loss - EUR | - | 9.369 | 13.697 | 16.059 | 15.750 | 11.215 | 16.144 | 13.719 | 14.820 | 12.998 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Endomed Dr. David Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 9.825 | 15.088 | 17.315 | 16.716 | 12.180 | 16.915 | 15.511 | 29.507 | 15.983 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 74 | 0 | 0 | 0 | 12.583 | 0 |
| Cash | - | 9.825 | 15.088 | 17.315 | 16.642 | 12.180 | 16.915 | 15.511 | 16.923 | 15.983 |
| Shareholders Funds | - | 9.414 | 13.750 | 16.111 | 15.801 | 11.264 | 16.193 | 13.768 | 28.546 | 13.046 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 411 | 1.339 | 1.204 | 915 | 916 | 722 | 1.743 | 961 | 2.936 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Endomed Dr. David Srl